Prestige BioPharma Limited 950210.KS Stock
Prestige BioPharma Limited Price Chart
Prestige BioPharma Limited 950210.KS Financial and Trading Overview
| Prestige BioPharma Limited stock price | 8050 KRW |
| Previous Close | 10250 KRW |
| Open | 10420 KRW |
| Bid | 10290 KRW x N/A |
| Ask | 10330 KRW x N/A |
| Day's Range | 10250 - 10480 KRW |
| 52 Week Range | 7020 - 13500 KRW |
| Volume | 36.37K KRW |
| Avg. Volume | 151.4K KRW |
| Market Cap | 620.19B KRW |
| Beta (5Y Monthly) | 1.047212 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
950210.KS Valuation Measures
| Enterprise Value | 507.04B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.658 |
Trading Information
Prestige BioPharma Limited Stock Price History
| Beta (5Y Monthly) | 1.047212 |
| 52-Week Change | -8.88% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 13500 KRW |
| 52 Week Low | 7020 KRW |
| 50-Day Moving Average | 10503.8 KRW |
| 200-Day Moving Average | 9367.1 KRW |
950210.KS Share Statistics
| Avg. Volume (3 month) | 151.4K KRW |
| Avg. Daily Volume (10-Days) | 76.89K KRW |
| Shares Outstanding | 60.1M |
| Float | 19.17M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.013% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -13.46% |
| Return on Equity (ttm) | -16.69% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -228950000 KRW |
| EBITDA | -138592583680 KRW |
| Net Income Avi to Common (ttm) | -74933575680 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 295.89B KRW |
| Total Cash Per Share (mrq) | 4914.57 KRW |
| Total Debt (mrq) | 72.96B KRW |
| Total Debt/Equity (mrq) | 13.03 KRW |
| Current Ratio (mrq) | 3.928 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -46472220672 KRW |
| Levered Free Cash Flow (ttm) | -97308336128 KRW |
Profile of Prestige BioPharma Limited
| Country | South Korea |
| State | N/A |
| City | Singapore |
| Address | 21 Biopolis Road |
| ZIP | 138567 |
| Phone | 65 6924 6535 |
| Website | https://www.prestigebiopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Prestige BioPharma Limited, a biopharmaceutical company, engages in the research, development, and marketing of biosimilars and new antibody therapeutics in the Asia Pacific. The company primarily engages in the development of new and similar antibody drugs for solid tumor, pancreatic cancer, breast cancer, gastric cancer, and arthritis. It is also developing vaccines for COVID-19 virus. The company was incorporated in 2015 and is headquartered in Singapore.
Q&A For Prestige BioPharma Limited Stock
What is a current 950210.KS stock price?
Prestige BioPharma Limited 950210.KS stock price today per share is 8050 KRW.
How to purchase Prestige BioPharma Limited stock?
You can buy 950210.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Prestige BioPharma Limited?
The stock symbol or ticker of Prestige BioPharma Limited is 950210.KS.
Which industry does the Prestige BioPharma Limited company belong to?
The Prestige BioPharma Limited industry is Biotechnology.
How many shares does Prestige BioPharma Limited have in circulation?
The max supply of Prestige BioPharma Limited shares is 60.1M.
What is Prestige BioPharma Limited Price to Earnings Ratio (PE Ratio)?
Prestige BioPharma Limited PE Ratio is now.
What was Prestige BioPharma Limited earnings per share over the trailing 12 months (TTM)?
Prestige BioPharma Limited EPS is 0 KRW over the trailing 12 months.
Which sector does the Prestige BioPharma Limited company belong to?
The Prestige BioPharma Limited sector is Healthcare.